BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17879918)

  • 21. Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate.
    Promkhatkaew D; Pinyosukhee N; Thongdeejaroen W; Sutthent R; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):113-22. PubMed ID: 19323043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.
    von Reyn CF; Mtei L; Arbeit RD; Waddell R; Cole B; Mackenzie T; Matee M; Bakari M; Tvaroha S; Adams LV; Horsburgh CR; Pallangyo K;
    AIDS; 2010 Mar; 24(5):675-85. PubMed ID: 20118767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disseminated Bacillus Calmette-Guerin infection after BCG vaccination.
    Rezai MS; Khotaei G; Mamishi S; Kheirkhah M; Parvaneh N
    J Trop Pediatr; 2008 Dec; 54(6):413-6. PubMed ID: 18593737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species.
    Murphy D; Corner LA; Gormley E
    Tuberculosis (Edinb); 2008 Jul; 88(4):344-57. PubMed ID: 18222731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No adverse events after simultaneous administration of 50 000 IU vitamin A and Bacille Calmette-Guerin vaccination to normal-birth-weight newborns in Guinea-Bissau.
    Nante JE; Diness BR; Ravn H; Roth A; Aaby P; Benn CS
    Eur J Clin Nutr; 2008 Jul; 62(7):842-8. PubMed ID: 17538544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disseminated cutaneous bacille Calmette-Guérin infection identified by polymerase chain reaction in a patient with X-linked severe combined immunodeficiency.
    Huang LH; Shyur SD; Weng JD; Shin-Chi ; Huang FY; Tzen CY
    Pediatr Dermatol; 2006; 23(6):560-3. PubMed ID: 17155998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin.
    Waters WR; Palmer MV; Nonnecke BJ; Thacker TC; Scherer CF; Estes DM; Jacobs WR; Glatman-Freedman A; Larsen MH
    Vaccine; 2007 Nov; 25(45):7832-40. PubMed ID: 17931755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune reconstitution syndrome precipitated by bacille Calmette Guerin after initiation of antiretroviral therapy.
    Siberry GK; Tessema S
    Pediatr Infect Dis J; 2006 Jul; 25(7):648-9. PubMed ID: 16804439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concerns on Bacille Calmette-Guerin vaccination in infants born to mothers with hepatitis B virus infection.
    Hu Y; Zhou YH
    Vaccine; 2009 Mar; 27(14):1987-8. PubMed ID: 19428825
    [No Abstract]   [Full Text] [Related]  

  • 30. Disseminated granulomatous disease in a simian immunodeficiency virus- and bacille Calmette-Guèrin-infected rhesus monkey.
    Chen ZW; Zhou D; Chalifoux L; Lee-Parritz D; Mansfield K; Lord CI; Letvin NL
    AIDS; 1997 Feb; 11(2):266-7. PubMed ID: 9030386
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
    Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
    J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants.
    Almeida Vde C; Mussi-Pinhata MM; De Souza CB; Kubo CA; Martinez EZ; Carneiro-Sampaio MM; Duarte G
    Vaccine; 2009 Jun; 27(29):3856-61. PubMed ID: 19443091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
    Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS.
    Weltman AC; Rose DN
    AIDS; 1993 Feb; 7(2):149-57. PubMed ID: 8466679
    [No Abstract]   [Full Text] [Related]  

  • 36. Mother-to-child transmission of GB virus C in a cohort of women coinfected with GB virus C and HIV in Bangkok, Thailand.
    Bhanich Supapol W; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; McNicholl JM; Vanprapar N; Asavapiriyanont S; Shaffer N; Butera S
    J Infect Dis; 2009 Jul; 200(2):227-35. PubMed ID: 19508162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma Low producer genotype +874 overrepresented in Bacillus Calmette-Guerin nonresponding children.
    Anuradha B; Rakh SS; Ishaq M; Murthy KJ; Valluri VL
    Pediatr Infect Dis J; 2008 Apr; 27(4):325-9. PubMed ID: 18379373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCG osteomyelitis caused by the BCG Tokyo strain and confirmed by molecular method.
    Kim SH; Kim SY; Eun BW; Yoo WJ; Park KU; Choi EH; Kim EC; Lee HJ
    Vaccine; 2008 Aug; 26(34):4379-81. PubMed ID: 18603342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of maternal human immunodeficiency virus infection on birth outcomes and infant survival in rural Mozambique.
    Naniche D; Bardají A; Lahuerta M; Berenguera A; Mandomando I; Sanz S; Aponte JJ; Sigauque B; Alonso PL; Menéndez C
    Am J Trop Med Hyg; 2009 May; 80(5):870-6. PubMed ID: 19407140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.